Manning & Napier Group's GMAB Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 82 shares of Genmab A/S (GMAB) worth $4,632, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 4 quarters.
Based on 13F filings, Manning & Napier Group has maintained this position in GMAB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 35 shares. Largest reduction occurred in Q1 2026, reducing 18 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Genmab A/S (GMAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Genmab A/S (GMAB) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +35 | Add 74.47% | 82 | $56.49 |
| Q2 2026 | -7 | Reduce 12.96% | 47 | $26.02 |
| Q1 2026 | -18 | Reduce 25.00% | 54 | $25.83 |
| Q4 2025 | +72 | New Buy | 72 | $31.49 |
Manning & Napier Group's Genmab A/S Investment FAQs
Manning & Napier Group first purchased Genmab A/S (GMAB) in Q4 2025, acquiring 72 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Genmab A/S (GMAB) for 4 quarters since Q4 2025.
Manning & Napier Group's largest addition to Genmab A/S (GMAB) was in Q4 2025, adding 72 shares worth $2,267.
According to the latest 13F filing for Q3 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 82 shares of Genmab A/S (GMAB), valued at approximately $4,632.
As of the Q3 2026 filing, Genmab A/S (GMAB) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Genmab A/S (GMAB) was 82 shares, as reported at the end of Q3 2026.